| For: | Liu J, Song XY, Li XT, Yang M, Wang F, Han Y, Jiang Y, Lei YX, Jiang M, Zhang W, Tang DQ. β-Arrestin-2 enhances endoplasmic reticulum stress-induced glomerular endothelial cell injury by activating transcription factor 6 in diabetic nephropathy. World J Diabetes 2024; 15(12): 2322-2337 [PMID: 39676815 DOI: 10.4239/wjd.v15.i12.2322] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v15/i12/2322.htm |
| Number | Citing Articles |
| 1 |
Jian Yang, Cheng-Zhi Zhang, Jing Zhang. From metabolic regulation to kidney protection: β-arrestin 2 as a dual-function therapeutic target. World Journal of Diabetes 2025; 16(3): 102014 doi: 10.4239/wjd.v16.i3.102014
|
| 2 |
Ariella C. Avigad, Melody Zhou, Chengyu Sun, Levin Ma, Xue Li, Rosie J. Blodgett, Vera S. Donnenberg, Albert D. Donnenberg, Patrick L. Wagner, David L. Bartlett, Kunhong Xiao. Pharmacology of GPCRs Biased Signaling and Agonists. Handbook of Experimental Pharmacology 2025; 290: 277 doi: 10.1007/164_2025_773
|
| 3 |
Na Liu, Wei-Tao Yan, Kun Xiong. Exploring a novel mechanism for targeting β-arrestin-2 in the management of diabetic nephropathy. World Journal of Diabetes 2025; 16(4): 101994 doi: 10.4239/wjd.v16.i4.101994
|
